dexmedetomidine has been researched along with Paralysis, Legs in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agoston, VA; Bell, MT; Freeman, KA; Fullerton, DA; Herson, PS; Mares, J; Puskas, F; Reece, TB | 1 |
| Altunbaş, K; Aslan, A; Baş, O; Buyukokuroglu, ME; Cemek, M; Cosar, M; Ela, Y; Eser, O; Fidan, H | 1 |
| Maze, M; Sanders, RD | 1 |
3 other study(ies) available for dexmedetomidine and Paralysis, Legs
| Article | Year |
|---|---|
Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Cell Survival; Cells, Cultured; Cytokines; Dexmedetomidine; Disease Models, Animal; Inflammation Mediators; Ligation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Paraplegia; Receptors, Adrenergic, alpha-2; Signal Transduction; Spinal Cord; Time Factors; Toll-Like Receptor 4 | 2014 |
Does dexmedetomidine reduce secondary damage after spinal cord injury? An experimental study.
Topics: Adrenergic alpha-Agonists; Animals; Antioxidants; Apoptosis; Dexmedetomidine; Disease Models, Animal; Disease Progression; Energy Metabolism; Female; Lipid Peroxidation; Male; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Paraplegia; Rabbits; Spinal Cord; Spinal Cord Injuries; Treatment Failure | 2009 |
Translational research: addressing problems facing the anesthesiologist.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthesiology; Animals; Anterior Horn Cells; Biomedical Research; Dexmedetomidine; Humans; Morphine; Nerve Degeneration; Paraplegia; Rats; Spinal Cord Ischemia | 2007 |